Aspirin Resistance and Stroke

Completed

Phase 2/3 Results N/A

Trial Description

The purpose of this study is to determine if PFA results correlate with ischemic event outcomes as well as bleeding complications. Hypothesis is antiplatelet agents will be more efficacious if they are administered in a dose-adjusted manner using PFA results as a guide.

Conditions

Interventions

  • Aspirin, clopidogrel Drug
    Other Names: Plavix
    Intervention Desc: ASA 81 mg QD, ASA 325 mg QD, Clopidogrel 75 mg QD

Trial Design

  • Masking: Open Label
  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study
  • Intervention: Single Group Assignment

Outcomes

Type Measure Time Frame Safety Issue
Primary PFA results correlating with ischemic events and bleeding complications 4 years Yes

Sponsors